Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOLOGY OF TUBERCULOSIS
5158PDF: 1969HTML: 7254Untitled: 188 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3077PDF: 1088HTML: 1722 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2974PDF: 1002HTML: 3061 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4234PDF: 1709HTML: 1097 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1567PDF: 1141HTML: 184 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2083PDF: 797HTML: 1629Figure 1: 196 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1889PDF: 719HTML: 681 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1468PDF: 695HTML: 216 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3789PDF: 731HTML: 1828 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1225PDF: 516HTML: 23005 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
559PDF: 198Html: 25 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1506PDF: 569HTML: 171 -
WHAT ARE FUNGAL INFECTIONS?
4066PDF: 2320HTML: 27555de Pauw: 222 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1320HTML: 371PDF: 797 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6792PDF: 3852HTML: 24854 -
-
THE CHALLENGE OF AML IN OLDER PATIENTS
2138PDF: 921HTML: 2147 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2789PDF: 1546HTML: 221 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1567PDF: 772HTML: 1220Figure 1: 157Figure 2: 173Figure 3: 168 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3452PDF: 1586HTML: 2663 -
-
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10398PDF: 6243HTML: 21755 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1691Suppl. Files: 837HTML: 405PDF: 710







